Male Breast Cancer
📧 Sign up to get email alerts when something new happens for Male Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-03-27Clinical Trial Update: Demographics, Characteristics and Outcomes of Male Breast Cancer Patients at Methodist Health System
This clinical trial update reports demographics, characteristics, and outcomes of male breast cancer patients treated at Methodist Health Sy…
-
CLINICAL_TRIALS research · 2026-02-25Clinical Trial Update: Collection of Specimens and Clinical Data for Patients With Recurrent or Metastatic Breast Cancer or Male Breast Cancer
This entry announces an ongoing Mayo Clinic clinical trial collecting specimens and clinical data from patients with recurrent or metastatic…
-
CLINICAL_TRIALS research · 2026-01-07Clinical Trial Update: ETHAN - ET for Male BC [Phase 2]
A Phase 2 trial named ETHAN is evaluating an ET-based therapy for male breast cancer. The study is currently recruiting.
-
CLINICAL_TRIALS other · 2025-01-22Clinical Trial Update: MALE Mamm Organoids
Clinical trial update indicating recruitment for MALE Mamm Organoids studying male breast cancer, sponsored by Regina Elena Cancer Institute…
-
CLINICAL_TRIALS trial_result · 2024-08-09Clinical Trial Update: Testosterone & Tamoxifen Trial [NA]
A clinical trial evaluating testosterone and tamoxifen for male breast cancer has been terminated.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-05-10Clinical Trial Update: Finasteride (MK-0906) and Male Breast Cancer - A Register-Based Nested Case-Control Study (MK-0906-162/2003.021).
This clinical trial update reports on a completed register-based nested case-control study investigating the potential association between f…
-
CLINICAL_TRIALS trial_result · 2024-03-07Clinical Trial Update: Sorafenib in Treating Patients With Metastatic Breast Cancer [Phase 2]
Phase 2 clinical trial of sorafenib in metastatic breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2024-01-30Clinical Trial Update: Pre-operative IRX-2 in Early Stage Breast Cancer (ESBC) [Phase 1]
Results from a Phase 1 pre-operative study of IRX-2 in early-stage breast cancer have been completed and posted, including cohorts with trip…
-
CLINICAL_TRIALS trial_result · 2021-03-11Clinical Trial Update: Phase II Trial of the Cyclin-Dependent Kinase Inhibitor PD 0332991 in Patients With Cancer [Phase 2]
Phase II trial of the CDK inhibitor PD 0332991 (palbociclib) in various adult solid tumors including colon and breast cancers has completed …
-
CLINICAL_TRIALS trial_result · 2020-02-10Clinical Trial Update: Vaccine Therapy in Combination With Rintatolimod and/or Sargramostim in Treating Patients With Stage II-IV HER2-Positive Breast Cancer [Phase 1, Phase 2]
A completed Phase 1/2 clinical trial evaluating vaccine therapy in combination with Rintatolimod and/or Sargramostim for HER2-positive breas…
-
CLINICAL_TRIALS trial_result · 2019-06-07Clinical Trial Update: Carboplatin and Eribulin Mesylate in Triple Negative Breast Cancer Patients [Phase 2]
Phase 2 clinical trial update investigating carboplatin and eribulin mesylate in triple-negative breast cancer.
-
CLINICAL_TRIALS trial_result · 2019-02-01Clinical Trial Update: CYP17 Lyase and Androgen Receptor Inhibitor Treatment With Seviteronel Trial (INO-VT-464-006; NCT02580448) [Phase 1, Phase 2]
This document reports the completion of a Phase 1/Phase 2 clinical trial evaluating seviteronel, a CYP17 lyase and androgen receptor inhibit…
-
CLINICAL_TRIALS trial_result · 2018-09-19Clinical Trial Update: Tamoxifen +/- GnRH Analogue vs Aromatase Inhibitor + GnRH Analogue in Male Breast Cancer Patients [Phase 3]
Phase 3 trial comparing tamoxifen +/- GnRH analogue versus aromatase inhibitor + GnRH analogue in male breast cancer; study completed.
-
CLINICAL_TRIALS trial_result · 2018-06-14Clinical Trial Update: Ganetespib, Paclitaxel, Trastuzumab and Pertuzumab for Metastatic Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer [Phase 1]
Phase 1 study evaluating ganetespib with paclitaxel, trastuzumab, and pertuzumab in metastatic HER2-positive breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2017-09-29Clinical Trial Update: Romidepsin and Abraxane in Treating Patients With Metastatic Inflammatory Breast Cancer [Phase 1, Phase 2]
A Phase 1/2 trial of romidepsin plus Abraxane in HER2-negative inflammatory and metastatic breast cancer was terminated, with results posted…
-
CLINICAL_TRIALS trial_result · 2017-08-10Clinical Trial Update: Veliparib, Cisplatin, and Vinorelbine Ditartrate in Treating Patients With Recurrent and/or Metastatic Breast Cancer [Phase 1]
Phase 1 trial evaluating the combination of veliparib with cisplatin and vinorelbine ditartrate in patients with recurrent and/or metastatic…
-
CLINICAL_TRIALS trial_result · 2017-07-26Clinical Trial Update: Doxorubicin Hydrochloride Liposome, Cyclophosphamide, and Trastuzumab in Treating Patients With Stage IV Breast Cancer [Phase 1, Phase 2]
Phase 1/2 study evaluating a regimen of liposomal doxorubicin, cyclophosphamide, and trastuzumab in stage IV HER2-positive breast cancer, in…
-
CLINICAL_TRIALS trial_result · 2017-05-25Clinical Trial Update: Vaccine Therapy in Treating Patients With Stage IV Breast Cancer [Phase 1, Phase 2]
A completed Phase 1/2 trial evaluated a vaccine therapy for stage IV breast cancer, including HER2-positive and male breast cancer cases, wi…
-
CLINICAL_TRIALS trial_result · 2017-05-10Clinical Trial Update: Sunitinib Malate, Paclitaxel, Doxorubicin Hydrochloride, and Cyclophosphamide Before Surgery in Treating Patients With Stage IIB-IIIC Breast Cancer [Phase 2]
Phase 2 trial evaluating a neoadjuvant regimen of sunitinib, paclitaxel, doxorubicin, and cyclophosphamide in stage IIB-IIIC breast cancer; …
-
CLINICAL_TRIALS trial_result · 2017-04-11Clinical Trial Update: Vaccine Therapy in Treating Patients With Stage IV Hormone Receptor Positive Breast Cancer [Phase 2]
Phase 2 trial update for an investigational vaccine therapy in stage IV hormone receptor-positive breast cancer has been terminated.
-
CLINICAL_TRIALS trial_result · 2017-01-19Clinical Trial Update: Lapatinib Ditosylate and Radiation Therapy in Treating Patients With Locally Advanced or Locally Recurrent Breast Cancer [Phase 2]
Phase 2 trial of lapatinib with radiation therapy for locally advanced or locally recurrent breast cancer; the study was terminated with res…
-
CLINICAL_TRIALS trial_result · 2016-04-21Clinical Trial Update: Paclitaxel and Bavituximab in Treating Patients With HER2-Negative Metastatic Breast Cancer [Phase 1]
Phase 1 trial of paclitaxel with bavituximab in HER2-negative metastatic breast cancer has completed; no efficacy results are provided in th…
-
CLINICAL_TRIALS trial_result · 2016-03-17Clinical Trial Update: Azacitidine and Entinostat in Treating Patients With Advanced Breast Cancer [Phase 2]
Phase 2 trial evaluating azacitidine in combination with entinostat in advanced breast cancer has completed and posted results.
-
CLINICAL_TRIALS trial_result · 2015-11-05Clinical Trial Update: Phase I-II Study of Vorinostat, Paclitaxel, and Bevacizumab in Metastatic Breast Cancer [Phase 1, Phase 2]
This clinical trial update reports results from a Phase I/II study of vorinostat with paclitaxel and bevacizumab in metastatic breast cancer…
-
CLINICAL_TRIALS trial_result · 2015-05-22Clinical Trial Update: Tipifarnib and Combination Chemotherapy in Treating Patients With Stage II or Stage III Breast Cancer [Phase 1, Phase 2]
Clinical trial update on tipifarnib in combination chemotherapy for stage II/III breast cancer, including Phase 1 and Phase 2 results comple…